These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6149709)

  • 1. Therapeutic efficacy of alpha-adrenoceptor blockade in primary and secondary Raynaud's syndrome.
    Cleophas TJ; van Lier HJ; Faaber P; Fennis JF; van't Laar A
    Angiology; 1984 Nov; 35(11):719-23. PubMed ID: 6149709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Raynaud's syndrome with adrenergic alpha-blockade with or without beta-blockade.
    Cleophas TJ; van Lier HJ; Fennis JF; van 't Laar A
    Angiology; 1984 Jan; 35(1):29-37. PubMed ID: 6141750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha and beta-blockade and beta-stimulation in Raynaud's syndrome: a double-blind, placebo controlled, single dose study.
    Cleophas TJ; Fennis JF; van 't Laar A
    Angiology; 1985 Apr; 36(4):219-25. PubMed ID: 2862814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of digital artery adrenoceptors in Raynaud's disease.
    Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
    Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Raynaud's phenomenon: effects of terazosin].
    Paterna S; Pinto A; Arrostuto A; Cannavò MG; Di Pasquale P; Cottone C; Licata G
    Minerva Cardioangiol; 1997 May; 45(5):215-21. PubMed ID: 9273472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnosis and treatment of Raynaud's phenomenon.
    Porter JM; Snider RL; Bardana EJ; Rösch J; Eidemiller LR
    Surgery; 1975 Jan; 77(1):11-23. PubMed ID: 1078555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistence of raynaud's phenomenon and chronic active hepatitis with hepatitis B antigen.
    Kim WK; Koff RS
    Digestion; 1974; 11(1-2):152-6. PubMed ID: 4156016
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists].
    Shcherbakov AB
    Vutr Boles; 1988; 27(6):55-8. PubMed ID: 3247706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Raynaud's syndrome with calcium entry blockers].
    Shcherbakov AB; Guseva NG; Mach ES
    Ter Arkh; 1987; 59(4):89-92. PubMed ID: 3296288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nicardipine in the treatment of Raynaud's phenomenon].
    Kahan A; Amor B; Menkès CJ
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):487-90. PubMed ID: 3303287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of presynaptic beta receptors in Raynaud's disease.
    Brotzu G; Falchi S; Mannu B; Montisci R; Petruzzo P; Staico R
    J Vasc Surg; 1989 Jun; 9(6):767-71. PubMed ID: 2542629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of Raynaud's phenomenon with alpha-lytic agents].
    Clément DL
    Rev Med Liege; 1980 Oct; 35(19):650-2. PubMed ID: 6109369
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicardipine in the treatment of Raynaud's phenomenon: a randomized double-blind trial.
    Kahan A; Amor B; Menkès CJ; Weber S; Guérin F; Degeorges M
    Angiology; 1987 Apr; 38(4):333-7. PubMed ID: 3555175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE
    J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Raynaud's syndrome, 2011].
    Takáts A; Garai I; Papp G; Hevér T; Csiki E; András C; Csiki Z
    Orv Hetil; 2012 Mar; 153(11):403-9. PubMed ID: 22390864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
    Rhedda A; McCans J; Willan AR; Ford PM
    J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind placebo-controlled trial of buflomedil in the treatment of Raynaud's phenomenon: six-month follow-up.
    Le Quentrec P; Lefebvre ML
    Angiology; 1991 Apr; 42(4):289-95. PubMed ID: 1673051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Raynaud's phenomenon].
    Tomčík M
    Cas Lek Cesk; 2016; 155(6):310-318. PubMed ID: 27917635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.